Applications will open Summer of 2025.

Eligibility Criteria

• Able to relocate to Bethesda, MD for the duration of the fellowship
• Trained in medical oncology, hematology, pediatric oncology, radiation oncology, or surgical oncology
• Strong interest in learning about immunotherapy
• Preference is given to those with an academic interest
• Open to U.S. and non-U.S. trained physicians (the latter requires ECFMG certification and completion of USMLE Step 1, 2, and 3)

Benefits

• Provides opportunities to understand how to design, write, and run clinical trials, how to treat patients, how to manage toxicities, as well as opportunities to work with multiple experimental agents
• Work with internationally recognized experts in immunotherapy
• Learn management of immune-related adverse events
• Develop experience in writing and running immunotherapy clinical trials
• Develop experience with a wide array of immunotherapy approaches
  • Cellular therapy (e.g., CAR-T or TCR transgenic approaches)
  • Combination immunotherapy approaches
  • Immune checkpoint inhibitors
  • Immunocytokines
  • Therapeutic vaccines
• Possibilities for attending and presenting at national/international meetings
• Attend and participate in regularly scheduled NIH immunotherapy conferences
• Make a difference in the lives of patients with cancer at the largest hospital in the world devoted solely to research
• Salary is based on applicable laws, regulations, and policies